3PBIOVIAN
↗Noáin (Navarra), Spain
3PBIOVIAN is a leading pan-European Contract Development and Manufacturing Organization (CDMO) formed in February 2024 through the merger of Spain-based 3P Biopharmaceuticals and Finland-based Biovian. The company provides end-to-end development and manufacturing services for the biopharmaceutical industry, covering the entire product lifecycle from preclinical development to full-scale commercial supply.
The organization specializes in a wide range of biological products, including recombinant proteins, monoclonal antibodies, biosimilars, and advanced therapy medicinal products (ATMPs) such as viral vectors (AAV, Adenovirus), cell therapies, and plasmid DNA. With manufacturing sites in Spain and Finland and a commercial office in Boston, 3PBIOVIAN serves a global client base of biotech and pharmaceutical companies.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:CDMO (Contract Development and Manufacturing Organization)
SIZE & FINANCIALS
Employees:501-1000
Revenue:$75M-$100M
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Total Raised:$15M+
Investors:Keensight Capital, Sodena, ERES IV (Elyan Partners)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Service Provider)
Modalities:mAb, Recombinant proteins, Viral vectors (AAV, Adenovirus), Cell therapy, Plasmid DNA, Biosimilars
Active Trials:25
Trial Phases:Phase 1: 10 | Phase 2: 8 | Phase 3: 5 | Phase 4: 2
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:3PBIOVIAN Group
Acquired By:Keensight Capital (Majority Shareholder) (2019-07-01)
Subsidiaries:Biovian Oy, 3P Biopharmaceuticals S.L.U.
Key Partnerships:Eleva (Strategic alliance for moss-based expression systems), Vaxcyte (Manufacturing partnership), Zhittya Genesis Medicine (Process development)
COMPETITION
Position:Leader
Competitors:Lonza, Catalent, WuXi Biologics, KBI Biopharma, Boehringer Ingelheim, AGC Biologics
LEADERSHIP
Key Executives:
Dámaso Molero Sánchez - Group CEO
Antti Nieminen - Deputy CEO
Elena Erroba - Chief Commercial Officer
Scientific Founders:Dámaso Molero Sánchez
Board Members:Pierre Remy (Keensight Capital), Tom Ransohoff (Industry Veteran), Javier Lopez Moras
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 3PBIOVIAN. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.